275 related articles for article (PubMed ID: 30451014)
1. Repurposing existing drugs: identification of irreversible IMPDH inhibitors by high-throughput screening.
Sarwono AEY; Mitsuhashi S; Kabir MHB; Shigetomi K; Okada T; Ohsaka F; Otsuguro S; Maenaka K; Igarashi M; Kato K; Ubukata M
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):171-178. PubMed ID: 30451014
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Bronopol and Disulfiram as Potential
Nan J; Zhang S; Zhan P; Jiang L
Molecules; 2020 May; 25(10):. PubMed ID: 32423116
[TBL] [Abstract][Full Text] [Related]
3. Phthalazinone inhibitors of inosine-5'-monophosphate dehydrogenase from Cryptosporidium parvum.
Johnson CR; Gorla SK; Kavitha M; Zhang M; Liu X; Striepen B; Mead JR; Cuny GD; Hedstrom L
Bioorg Med Chem Lett; 2013 Feb; 23(4):1004-7. PubMed ID: 23324406
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolic anilides as broad specificity inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors.
Lee S; Ku AF; Vippila MR; Wang Y; Zhang M; Wang X; Hedstrom L; Cuny GD
Bioorg Med Chem Lett; 2020 Dec; 30(24):127543. PubMed ID: 32931912
[TBL] [Abstract][Full Text] [Related]
5. A screening pipeline for antiparasitic agents targeting cryptosporidium inosine monophosphate dehydrogenase.
Sharling L; Liu X; Gollapalli DR; Maurya SK; Hedstrom L; Striepen B
PLoS Negl Trop Dis; 2010 Aug; 4(8):e794. PubMed ID: 20706578
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH.
Kirubakaran S; Gorla SK; Sharling L; Zhang M; Liu X; Ray SS; Macpherson IS; Striepen B; Hedstrom L; Cuny GD
Bioorg Med Chem Lett; 2012 Mar; 22(5):1985-8. PubMed ID: 22310229
[TBL] [Abstract][Full Text] [Related]
7. Selective and potent urea inhibitors of cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.
Gorla SK; Kavitha M; Zhang M; Liu X; Sharling L; Gollapalli DR; Striepen B; Hedstrom L; Cuny GD
J Med Chem; 2012 Sep; 55(17):7759-71. PubMed ID: 22950983
[TBL] [Abstract][Full Text] [Related]
8. Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening.
Leroux F; Bosc D; Beghyn T; Hermant P; Warenghem S; Landry V; Pottiez V; Guillaume V; Charton J; Herledan A; Urata S; Liang W; Sheng L; Tang WJ; Deprez B; Deprez-Poulain R
Eur J Med Chem; 2019 Oct; 179():557-566. PubMed ID: 31276900
[TBL] [Abstract][Full Text] [Related]
9. A novel cofactor-binding mode in bacterial IMP dehydrogenases explains inhibitor selectivity.
Makowska-Grzyska M; Kim Y; Maltseva N; Osipiuk J; Gu M; Zhang M; Mandapati K; Gollapalli DR; Gorla SK; Hedstrom L; Joachimiak A
J Biol Chem; 2015 Feb; 290(9):5893-911. PubMed ID: 25572472
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
Shah CP; Kharkar PS
Eur J Med Chem; 2018 Oct; 158():286-301. PubMed ID: 30223117
[TBL] [Abstract][Full Text] [Related]
11. Inosine 5'-Monophosphate Dehydrogenase (IMPDH) as a Potential Target for the Development of a New Generation of Antiprotozoan Agents.
Fotie J
Mini Rev Med Chem; 2018; 18(8):656-671. PubMed ID: 27334467
[TBL] [Abstract][Full Text] [Related]
12. Optimization of benzoxazole-based inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.
Gorla SK; Kavitha M; Zhang M; Chin JE; Liu X; Striepen B; Makowska-Grzyska M; Kim Y; Joachimiak A; Hedstrom L; Cuny GD
J Med Chem; 2013 May; 56(10):4028-43. PubMed ID: 23668331
[TBL] [Abstract][Full Text] [Related]
13. A potent "fat base" nucleotide inhibitor of IMP dehydrogenase.
Wang W; Hedstrom L
Biochemistry; 1998 Aug; 37(34):11949-52. PubMed ID: 9718319
[TBL] [Abstract][Full Text] [Related]
14. The antibiotic potential of prokaryotic IMP dehydrogenase inhibitors.
Hedstrom L; Liechti G; Goldberg JB; Gollapalli DR
Curr Med Chem; 2011; 18(13):1909-18. PubMed ID: 21517780
[TBL] [Abstract][Full Text] [Related]
15. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery.
Nair V; Shu Q
Antivir Chem Chemother; 2007; 18(5):245-58. PubMed ID: 18046958
[TBL] [Abstract][Full Text] [Related]
16. Triazole inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.
Maurya SK; Gollapalli DR; Kirubakaran S; Zhang M; Johnson CR; Benjamin NN; Hedstrom L; Cuny GD
J Med Chem; 2009 Aug; 52(15):4623-30. PubMed ID: 19624136
[TBL] [Abstract][Full Text] [Related]
17. Discovery of ebselen as an inhibitor of Cryptosporidium parvum glucose-6-phosphate isomerase (CpGPI) by high-throughput screening of existing drugs.
Eltahan R; Guo F; Zhang H; Xiang L; Zhu G
Int J Parasitol Drugs Drug Resist; 2018 Apr; 8(1):43-49. PubMed ID: 29414105
[TBL] [Abstract][Full Text] [Related]
18. The structural basis of Cryptosporidium -specific IMP dehydrogenase inhibitor selectivity.
Macpherson IS; Kirubakaran S; Gorla SK; Riera TV; D'Aquino JA; Zhang M; Cuny GD; Hedstrom L
J Am Chem Soc; 2010 Feb; 132(4):1230-1. PubMed ID: 20052976
[TBL] [Abstract][Full Text] [Related]
19. Novel adenosine-derived inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.
Shigetomi K; Sarwono AEY; Ichikawa S; Ubukata M
J Antibiot (Tokyo); 2019 Dec; 72(12):934-942. PubMed ID: 31296916
[TBL] [Abstract][Full Text] [Related]
20. Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis.
Umejiego NN; Gollapalli D; Sharling L; Volftsun A; Lu J; Benjamin NN; Stroupe AH; Riera TV; Striepen B; Hedstrom L
Chem Biol; 2008 Jan; 15(1):70-7. PubMed ID: 18215774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
